Stryker Corp
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually.
Trading 38% above its estimated fair value of $206.96.
Current Price
$331.54
+0.65%GoodMoat Value
$206.96
37.6% overvaluedStryker Corp (SYK) DCF Calculator
What is a DCF Calculator?
A Discounted Cash Flow (DCF) model estimates a company's intrinsic value by projecting its future cash flows and discounting them back to the present. The core idea: a dollar earned in the future is worth less than a dollar today.
Inputs
Cash flow, discount rate, terminal growth & projection years
Model
Projects cash flows forward, adds terminal value, discounts back
Output
Intrinsic value per share — compare with price for margin of safety
Enter a ticker on the left to auto-fill real financial data and get started.
SYK DCF Calculator — Discounted Cash Flow
Discounted Cash Flow (DCF) calculator for Stryker Corp (SYK). Estimate the intrinsic value of SYK stock by projecting future cash flows and discounting them to present value. The two-stage DCF model supports EPS-based, FCF-based, and dividend-based approaches.
Current EPS: $8.40. Free cash flow: $4.28B. FCF growth rate: 18.56%. WACC: 10.00%. Shares outstanding: 382.4M. GoodMoat fair value: $206.96.
The DCF calculator projects 10 years of cash flows at a user-adjustable growth rate, applies a terminal growth rate, and discounts all future cash flows back to present value using the weighted average cost of capital (WACC). A sensitivity table shows how the intrinsic value changes across different growth and discount rate assumptions. Use this tool alongside GoodMoat's reverse DCF and fair value models to triangulateStryker Corp's true worth.